CIK 0000921114
- Non-accelerated filer
- Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911549568
- Phone
- +1 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-09 | PATTI JOSEPH M Director | Grant or award · Stock Options (Right to Buy) | +25,640 | 25,640 | ||
| 2025-02-05 | PATTI JOSEPH M Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 54,343 | ||
| 2024-03-14 | PATTI JOSEPH M Director | Grant or award · Stock Options (Right to Buy) | +39,666 | 39,666 | ||
| 2024-03-14 | PATTI JOSEPH M Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 94,009 | ||
| 2023-12-21 | PATTI JOSEPH M Director | Grant or award · Stock Options (Right to Buy) | +10,461 | 10,461 | ||
| 2022-04-13 | PATTI JOSEPH M Director | Grant or award · Stock Options (Right to Buy) | +33,000 | 33,000 | ||
| 2021-06-07 | PATTI JOSEPH M Director | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2020-12-08 | PATTI JOSEPH M Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2019-05-22 | PATTI JOSEPH M Director | Grant or award · Stock Option (Right to Buy) | +27,383 | 27,383 |
Page 1 of 1 · 9 trades